Merit Medical Corp (MMSI) Narxning foydaga nisbati

Merit Medical Systems Inc - MMSI emitenti grafik logotipi

Merit Medical Systems (MMSI) kompaniyasining median P/E ko'rsatkichi barqaror pul oqimlarini namoyish etmoqda, chunki bir marta ishlatiladigan stentlarga bo'lgan talab inqirozlarga chidamli bo'lib qolmoqda, joriy koeffitsient esa 32.60 darajasida turibdi. Ushbu barqarorlik kuchli muhandislik jamoasi va xodimlarning past aylanish darajasi bilan mustahkamlanmoqda. Daromadlar o'sishi zamonaviy intervensiya radiologiyasi va onkologiyasi uchun muhim bo'lgan yuqori marjali kateterlar va embolik tizimlar hisobiga ta'minlanmoqda.

Merit Medical (MMSI) - P/E multiplikatori 04.07.2022dan 10.11.2026gacha

Merit Medical Systems kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:merit.com, MMSI
Merit Medical Systems tovar namunasi

Merit Medical Systems (MMSI) uchun bozor kapitalizatsiyasining sof foydaga nisbati jarrohlar ishonchi va qat'iy FDA nazorati ostidagi patentlar barqarorligining qiymatini aks ettiradi. Kompaniyaning 32.60 darajasida qayd etilgan P/E trayektoriyasini tahlil qilish orqali investor kapital konsentratsiyasi risklarini minimallashtirish uchun joriy kotirovkani biznesning haqiqiy rentabelligi bilan solishtirib, aktivning haddan tashqari qimmat baholanganlik darajasini aniqlaydi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori intuitive.com|Narxning foydaga nisbati Danaher (DHR)|Narxning foydaga nisbati BDX (BD)|STERIS Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WST|Baxter International - P/E multiplikatori|Biznesning o‘zini qoplash muddati masimo.com MASI|Stevanato Group (STVN) - Narxning foydaga nisbati|Narx-foyda multiplikatori TFX|Narxning foydaga nisbati Envista Holdings Corp|ICU Medical Inc. (ICUI) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti XRAY (DENTSPLY SIRONA Inc.)|Bozor narxining sof foydaga nisbati LMAT|Narxning foydaga nisbati AtriCure ATRC|Kompaniya qiymatining sof foydaga nisbati STAA|NAGE: Narx-foyda koeffitsiyenti|ZIMV - P/E multiplikatori|AngioDynamics, Inc. (ANGO) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti cerus.com|TKNO (Teknova) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Monogram Technologies Inc. MGRM|Narxning foydaga nisbati Sharps Technology, Inc. (STSS)|infusystem.com - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems, Inc.)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc. MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Zentek Corp|ELUT (Elutia Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati milestonescientific.com MLSS|Narxning foydaga nisbati NEXGEL (NXGL)|RVP (retractable.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori HBIO (Harvard Bioscience)|Biznesning o‘zini qoplash muddati Femasys Corporation (FEMY)|MHUA: Narx-foyda koeffitsiyenti|Predictive Oncology - Bozor narxining sof foydaga nisbati|CJMB (callanjmb.com) - Narx-foyda koeffitsiyenti|Atrion Corp. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NeuroMetrix Corp